摘要
缺血性卒中是导致我国成年人神经功能障碍的主要原因,快速、及时、准确预测卒中后结局并干预治疗至关重要。目前,对缺血性卒中预后的预测主要依靠神经影像学和临床评估,缺乏客观简便的快速预测工具。近年来研究显示,早期测定外周血来源的生物标志物或可预测卒中患者结局,从而优化卒中管理,提高患者康复效率,改善卒中结局。该文对外周血生物标志物与缺血性卒中临床预后预测的相关性研究进展进行了综述。
Ischemic stroke(IS)is the main cause of neurological dysfunction in adults in China,and rapid,timely,and accurate prediction of post-stroke outcome and intervention treatment are crucial.Currently,the prognosis of ischemic stroke mainly relies on neuroimaging and clinical assessment,and there is still a lack of objective and simple rapid prediction tools.Recent studies have shown that early measurement of peripheral blood-derived biomarkers may be able to predict stroke patient outcomes,thereby optimizing stroke management,improving patient rehabilitation,and improving stroke outcomes.This article reviews the progress of studies on the correlation between peripheral blood biomarkers and clinical prognosis of ischemic stroke.
作者
单晓倩
常军
宋京京
罗泳茵
郝楠
赵岚
Shan Xiaoqian;Chang Jun;Song Jingjing;Luo Yongyin;Hao Nan;Zhao Lan(Department of Acupuncture and Moxibustion,the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300381,China)
出处
《中国脑血管病杂志》
CAS
CSCD
北大核心
2023年第12期850-856,共7页
Chinese Journal of Cerebrovascular Diseases
基金
国家自然科学基金资助项目(82074533)。
关键词
生物标记
缺血性卒中
预测价值
外周血样
综述
Biomarkers
Ischemic stroke
Predictive value
Peripheral blood samples
Review
作者简介
通信作者:赵岚,Email:lanzhao69@163.com。
